As a newly discovered immune checkpoint expressed on APC cells and tumor cells, VTCN1 is expected to become a novel target for immunotherapy in the future despite its regulatory mechanism in cancer immunity remained to be further explored [37]. The gene discussed is VTCN1; the disease is neoplasm.